Clovis Oncology's shares have fallen by roughly 15% since the biotech disclosed the halting of a Phase 2 study of Rubraca in recurrent, metastatic bladder cancer....

An experimental gene therapy for hemophilia A helped to restore activity of an essential blood-clotting protein in several patients with the blood disorder, boost...